Gallagher SJ - Search Results

1

The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

Gallagher SJ, Mijatov B, Gunatilake D, Tiffen JC, Gowrishankar K, Jin L, Pupo GM, Cullinane C, Prinjha RK, Smithers N, McArthur GA, Rizos H, Hersey P. Gallagher SJ, et al. J Invest Dermatol. 2014 Nov;134(11):2795-2805. doi: 10.1038/jid.2014.243. Epub 2014 Jun 6. J Invest Dermatol. 2014. PMID: 24906137 Free article.

2

Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis.

Gallagher S, Kefford RF, Rizos H. Gallagher S, et al. Cell Cycle. 2005 Mar;4(3):465-72. doi: 10.4161/cc.4.3.1526. Epub 2005 Mar 7. Cell Cycle. 2005. PMID: 15701968

3

The ARF tumour suppressor.

Gallagher SJ, Kefford RF, Rizos H. Gallagher SJ, et al. Int J Biochem Cell Biol. 2006;38(10):1637-41. doi: 10.1016/j.biocel.2006.02.008. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16600663 Review.

4

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.

Gallagher SJ, Thompson JF, Indsto J, Scurr LL, Lett M, Gao BF, Dunleavey R, Mann GJ, Kefford RF, Rizos H. Gallagher SJ, et al. Neoplasia. 2008 Nov;10(11):1231-9. doi: 10.1593/neo.08702. Neoplasia. 2008. PMID: 18953432 Free PMC article.

5

Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondria.

Irvine M, Philipsz S, Frausto M, Mijatov B, Gallagher SJ, Fung C, Becker TM, Kefford RF, Rizos H. Irvine M, et al. Among authors: gallagher sj. Cell Cycle. 2010 Feb 15;9(4):829-39. doi: 10.4161/cc.9.4.10785. Epub 2010 Mar 2. Cell Cycle. 2010. PMID: 20107316

6

Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.

Lai F, Jin L, Gallagher S, Mijatov B, Zhang XD, Hersey P. Lai F, et al. Adv Pharmacol. 2012;65:27-43. doi: 10.1016/B978-0-12-397927-8.00002-6. Adv Pharmacol. 2012. PMID: 22959022 Review.

7

The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.

Wroblewski D, Mijatov B, Mohana-Kumaran N, Lai F, Gallagher SJ, Haass NK, Zhang XD, Hersey P. Wroblewski D, et al. Among authors: gallagher sj. Carcinogenesis. 2013 Feb;34(2):237-47. doi: 10.1093/carcin/bgs330. Epub 2012 Oct 20. Carcinogenesis. 2013. PMID: 23087082

8

A focus on PD-L1 in human melanoma.

Hersey P, Gallagher S. Hersey P, et al. Clin Cancer Res. 2013 Feb 1;19(3):514-6. doi: 10.1158/1078-0432.CCR-12-3312. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251000

9

Intralesional immunotherapy for melanoma.

Hersey P, Gallagher S. Hersey P, et al. J Surg Oncol. 2014 Mar;109(4):320-6. doi: 10.1002/jso.23494. Epub 2013 Dec 3. J Surg Oncol. 2014. PMID: 24301265 Review.

10

EZH2: an emerging role in melanoma biology and strategies for targeted therapy.

Tiffen J, Gallagher SJ, Hersey P. Tiffen J, et al. Among authors: gallagher sj. Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27. Pigment Cell Melanoma Res. 2015. PMID: 24912396 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters